• EcoPhage is focused on discovering and developing environmentally friendly products for disease control in agriculture. The company's technology uses bacteriophages (viruses that attack bacteria)...

    Read more

  • Weizmann Institute Recognized for High Performance by U-Multirank

    U-Multirank, a leading European initiative that ranks universities worldwide based on a number of key performance...

    Read more

  • A Stem of Support: PLX Stem Cells Provide COVID-19 Relief

    Pluristem was founded in 2001 by Shai Meretzki of the Technion, who made use of a stem cell patent which was developed during his...

    Read more

  • Prof Alon Harmelin and Dr. Slava Kalchenko, two Weizmann Institute scientists, developed TOVA – a innovative imaging system that can diagnose and monitor subdural hematomas frequently caused by...

    Read more

  • The Weizmann Institute and the Institute for Biological Research join hands to advance COVID-19 research.

    The Coronavirus pandemic has prompted relevant responses from organizations from...

    Read more

  • המרוץ אחר התרופה לקורונה: הצצה נדירה למעבדות של מכון וייצמן

    מאז פרוץ מגפת הקורונה במכון ויצמן שברחובות מתנהלת מלחמה נגד הנגיף, במטרה למצוא כמה שיותר מהר חיסון או תרופה...

    Read more

  • An Introduction to the Basic Complexities of Technology Transfer. Les Nouvelles, the journal of the Licensing Executives Society International (LES), recently published a fascinating article on...

    Read more

  • Ness Ziona, Israel – March 31, 2020: BiomX, a clinical stage company and a subsidiary of YEDA, the Weizmann Institute's technology transfer arm, recently announced that its positive Phase 1 data...

    Read more

  • An innovative Weizmann Institute initiative helps individuals track their sense of smell and potentially detect early signs of COVID-19.

    ...

    Read more

  • The Coronavirus pandemic is forcing us all to confront the relative lack of anti-viral treatments that humanity has in its armamentarium. At the Weizmann Institute of Science, we confront this...

    Read more

  • On January 28th, Grove Ventures launched Frontier Tech, Israel's first “Deep Tech” conference. Yeda was a major partner in organizing this groundbreaking conference, helping Grove Ventures select...

    Read more

  • Deerfield Commits up to $130 million to Advance New Medicines at Israeli Institute Through a Newly Launched Company

    (Rehovot, Israel and New York, NY, January 6, 2019) - ...

    Read more

  • Yeda, the Commercial Arm of the Weizmann Institute of Science, and Deerfield Create Orchard Innovations, LLC

    Deerfield Commits up to $130 million to Advance New Medicines at the Israeli...

    Read more

  • The prestigious Leiden ranking puts the impact of Institute research high up in a list of the top universities and research institutes 08.07.2018

    The Weizmann Institute of Science has been...

    Read more

  • Tel Aviv --   February 1,  2016:   NewCO2Fuels  (NCF), an Israeli start-up which transforms CO2 emissions into a clean fuel that can be sold as a commodity at competitive prices, was anno unced as...

    Read more

  • Naiberg to head technology transfer at UCLA

    After 15 years at Yeda Research and Development Co. Ltd., the technology transfer arm of the Weizmann Institute of Science,...

    Read more

  • Originally printed as an advertisement feature in Nature, Vol. 533, No. 7601 (5 May 2016)

    One cannot predict what scientific discoveries or revolutions will be made in the laboratories of...

    Read more

  •  

    EAU TV spoke to Mark Emberton, UCL, and Eva Johannsen, University of Gothenburg at EAU16 about the use and limitations of active surveillance, how it affects quality of life, and a new...

    Read more

  • MabTrix is a preclinical-stage biopharmaceutical company developing a function-blocking therapeutic monoclonal antibody (...

    Read more

  • miCure Therapeutics is a biotechnology company leveraging microRNA-based therapeutics and diagnostics for neurodegenerative and psychiatric...

    Read more

  • On-Sight, a joint venture of the Weizmann Institute and NYU, has developed AI based software that...

    Read more

  • ImmunArray, developer of the iCHIP™, a groundbreaking in-vitro auto-antibody profiling platform is pleased to announce the launch of their first commercial diagnostic product, SLE-key™ Rule Out,...

    Read more

  • Darmstadt, Germany, and Rehovot, Israel, February 16, 2016 – Merck, a leading science and technology company, today extended the partnership with Weizmann Institute of Science, Rehovot, Israel, of...

    Read more

  • Alma Bio Therapeutics is a biotechnology company pioneering a new class of therapeutic that reinforces the natural built-in mechanism...

    Read more

  • ImmunoBrain Therapies Inc. develops therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS and AMD. While there is no...

    Read more

  • Pantheon Bioscience develops molecular tools based on new anti-phage defense systems discovered by Professor Rotem Sorek's lab at the...

    Read more
  • ,

    WiScan® Hermes is a High content screening Fluorescence and Bright Field scanning system which operates at extremely high speeds of image acquisition, and generates exceptionally high quality...

    Read more

  • Darmstadt, Germany, and Rehovot, Israel, February 16, 2016 – Merck, a leading science and technology company, announced that the Weizmann Institute conferred the renowned Weizmann Award in the...

    Read more

  • NanoCell Ltd. is dedicated to advancing women’s reproductive health through biopharmaceutical technologies that significantly improve embryo implantation, consequently increasing the chances of...

    Read more

  • Immunity Pharma (IPL) develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS),...

    Read more

  • Curesponse is a clinical-stage cancer diagnostics company developing a three-dimensional tissue culture system for modeling cancer growth...

    Read more

  • Vitamin Alpha D3 is a molecule discovered by Institute researchers and produced under license by Teva Pharmaceuticals Ltd. for the treatment of osteoporosis and bone decalcification.

    ...

    Read more

  • Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where...

    Read more

  • ImmunArray (IAL) is developing in-vitro diagnostic tests based on its iCHIP microarray technology platform. The products support a...

    Read more

  • Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company...

    Read more

  • Centre Hospitalier Universitaire (CHU) d'Angers in France is conducting a clinical trial of RP103 called "CYST-HD Multicentre study of treatment of Huntington’s Disease with cysteamine, a...

    Read more

  • Weizmann Institute Drug, TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico

    A therapy invented at the Weizmann Institute of Science and clinically developed...

    Read more

  • DayTwo is a microbiome-based precision medicine company developing personalized nutrition, diagnostic, and therapeutic solutions using...

    Read more

  • IDEA Bio-Medical is a commercial-stage company specializing in solutions for biological cell-imaging research, drug-discovery automation, and...

    Read more

  • Moodify develops unique active scents designed to help people improve their performance, enhance their wellbeing, and increase their safety...

    Read more
  • ,

    (Recombinant interferon beta), identical to the native molecule and registered for the treatment of multiple sclerosis and several viral diseases, licensed to Inter-Lab Ltd., a Serono company.  ...

    Read more

  • NCF’s technology, which captures CO2 emissions and turns them into fuel, may offer an alternative to cutting back on greenhouse gases

    DAPHNE ROUSSEAU. 2015

     

    The company...

    Read more

  • Tech Republic, 2 December

    http://www....

    Read more

  • BiomX is a microbiome company developing customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as...

    Read more

  • HY BIOPHARMA INC. is a dermatology specialty company focused on the development of its innovative photodynamic therapy using topically-applied synthetic hypericin with safe visible light, to treat...

    Read more

  • Liposphere is a biomedical start-up developing a platform of highly lubricous, water-based biocompatible nanomaterials for conditions in...

    Read more

  • NanoLubTM, is the world’s first commercial solid lubricant based on spherical inorganic nanoparticles. NanoLubTM reduces friction & wear significantly better than conventional lubricants....

    Read more

  • ImmunArray Ltd announces the Launch of the SLE-key™ Rule Out test to be run out of VERACIS the Company’s Service Laboratory beginning in March 2015, in Richmond, Virginia Richmond, VA and Rehovot...

    Read more

  • Geneformics is innovating in the field of Information Technology for genomics. The company’s products employ compression and other cutting-edge technologies to streamline the storage and sharing...

    Read more

  • NewCO2Fuels commercializes a technology that uses high-temperature CO2 dissociation to convert CO2 into a variety of fuels. The core...

    Read more

  • FortePhest is a biotechnology start-up developing a technology to combat herbicide‐resistant weeds.

    FortePhest is developing H-Forte, a...

    Read more

  • GeneCards® is a searchable, integrated database of human genes that provides concise genomic related information, on all known and predicted human genes

    The GeneCards human gene database...

    Read more

  • XL-protein from Germany and Yeda, the commercial arm of the Weizmann Institute of Science, have announced the signing of a collaboration agreement for the commercial exploitation of an improved...

    Read more

  • SynVaccine has developed a CAD/CAM platform for designing and fabricating designer viruses for biotechnology. The company utilizes a...

    Read more

  • Catalyst AgTech has developed a self-destruct mechanism that is used in persistent pesticides, herbicides, and...

    Read more

  • EcoBreed develops solutions to fast-track natural plant breeding. The company's technological platform, BreedFit, enables rapid and...

    Read more

  • Kibbutz Dorot is the largest producer of garlic in Israel.

    Following research conducted at the Weizmann Institute of Science, Kibbutz Dorot has developed a garlic capsule – a revolutionary...

    Read more

  • An Israeli-Australian venture will use solar technology developed at the Weizmann Institute of Science to reduce carbon dioxide emissions from the burning of brown coal. The venture has been...

    Read more

  • NeuroQuest is developing a blood-based diagnostic test for Alzheimer's disease. The technology is based on the specific...

    Read more

  • LifeMap Sciences develops and commercializes next-generation sequencing (NGS) analysis solutions. The company's core technology, the GeneCards...

    Read more

  • Metabolic Insights aims to develop novel eco-friendly and sustainable products based on purified molecules from plants. The company...

    Read more

  • Janssen Research & Development announced several new collaborations through its Janssen Human Microbiome Institute (JHMI) focused on advancing the discovery, development and commercialization...

    Read more

  • Native interferon beta), licensed to Inter-Lab Ltd., a Serono company, and used as an antiviral and anti-cancer drug, with sales exceeding 40$ million annually, until replaced by Rebif®.

  • 3i to Develop Microscopes of the Future Based on Weizmann Institute Inventions

    Yeda, the technology transfer arm of the Weizmann Institute of Science, has signed a license agreement with ’...

    Read more

  • Photomyne is an application that enables users to digitally capture entire photo albums in minutes. The company's technology allows users to...

    Read more

  • OPKO Biologics, formerly F.K.A. PROLOR Biotech, develops proprietary versions of therapeutic proteins and peptide drugs...

    Read more

  • An antibody based therapy presenting synergism with conventional chemotherapy. The synergistic effect was invented at the Weizmann Institute. Erbitux was developed by ImClone Systems and approved...

    Read more

  • Prolor received approval for a new patent by the Patent Authority in the U.S. for its RPEG platform. Prolor’s medicine for obesity and Type-2 diabetes is based on this platform.

    ...

    Read more

  • ColoRight is a hair coloring and diagnostic system that uses spectroscopy to assess the composition and relative...

    Read more

  • NDS Group Ltd. was established in 1985 and developed smart cards to prevent unauthorized access to computer data and satellite television broadcasts. The technology is based on an algorithm...

    Read more

  • The Weizmann Institute of Science in Rehovot, Israel, and Yeda Research and Development Co., Ltd., its commercial arm, announced this week that they have entered a multi-year arrangement with...

    Read more

  • A recombinant hepatitis B vaccine that integrates the S, pre-S1, and pre-S2 surface proteins of the hepatitis B virus. Enables successful immunization with significantly lower doses of vaccine...

    Read more

  • ALAMEDA, Calif.--(BUSINESS WIRE)--

    BioTime, Inc. (NYSE MKT: BTX) and LifeMap Sciences, Inc. announce the launch of MalaCards, a new database of human diseases that is based on their leading...

    Read more

  • Pluristem Therapeutics is a regenerative medicine company developing a platform of novel biological products. PLX, a placenta-based cell...

    Read more
  • ,

    Kadimastem develops industrial regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to...

    Read more

  •  

    CDR1-based peptide derived from a human anti-DNA antibody. The peptide was shown to have a good safety profile. Clinical trial for systemic lupus erythematosus (SLE), are available.

  • The first innovative drug to be developed in Israel and to receive FDA approval, Copaxone® is a unique multiple sclerosis immunomodulator: the first and only non-interferon agent for the treatment...

    Read more

  • MOYA Bio is developing a novel class of tumor immune conditioning agents. The company's inhibitors of the FAT10 pathway...

    Read more

  • Optical Imaging is a medical device company providing ophthalmic equipment for early diagnosis, targeted treatment, and treatment...

    Read more

  • InterPharm Laboratories Ltd., founded in 1978 and today it is a subsidiary of Merck-Serono. For many years InterPharm was the largest biotechnology company in Israel, developing recombinant...

    Read more

  •  

    Recombinant copper-zinc Superoxide dismutase – (CuZnSOD) for prevention of pulmonary damage in neonates, licensed to Bio-Technology General, Inc., a subsidiary of Ferring Inc. The company...

    Read more

  • (Beta-carotene), a health food product with possible anti-cancer properties, extracted from Dunaliella, a local alga, licensed to Nikken Sohonsha...

    Read more

  • Kiralis Technologies Ltd is developing a commercial-level application for separating chiral molecules with only minor modifications for each...

    Read more

  • TeraGroup (Formerly Novatrans) introduces a comprehensive platform of partnerships and technological products including the TeraSystem (...

    Read more

  • BrainsWay develops advanced technology solutions for the treatment of a variety of brain disorders. The company's flagship technology is...

    Read more

  • DayTwo provides personalized nutrition and actionable insights that allow consumers to live healthier and maintain normal blood sugar levels. DayTwo does this through DNA sequencing of the gut...

    Read more

  • FreezeM offers a technology designed to improve the use of insects as a protein source for animal feed. Its products are designed to overcome a...

    Read more

  • Neurogenic researches and develops diagnostics and therapeutics for mental disorders. The company has developed a straightforward, highly...

    Read more

  • BiondVax Pharmaceuticals is a biopharmaceutical company developing a universal flu vaccine designed to provide multi-season and multi-strain...

    Read more

  • Yeda, the technology transfer arm of the Weizmann Institute of Science, has signed a license agreement with ’3i.’ Other microscopy systems based on Weizmann research are being sold by ‘Idea Bio-...

    Read more

  • A protocol that arose from Weizmann Institute of Science research has led to US Food and Drug Administration approval of a new biological drug for the treatment of a certain form of lung cancer....

    Read more

  • ImmunoBrain Checkpoint (IBC) is a biopharmaceutical company focused on developing a pipeline of disease-modifying immunotherapies for...

    Read more

  • NanoMaterials produces commercially viable inorganic, multilayered nanofullerenes and nanotubes based on patented platform technology developed...

    Read more

  • Phytolon provides an ultimate solution to the global food colors issue. Leveraging a novel and sustainable...

    Read more
  • ,

    STEBA Biotech is a privately owned biotechnology company headquartered in Luxembourg with offices in France, Israel, Switzerland, and the US.  
    Steba Biotech’s flagship product, TOOKAD®, for...

    Read more